LH
Roles
Therapeutic Areas
BeyondSpring Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Plinabulin + Docetaxel | 2L/3L Non-Small Cell Lung Cancer (NSCLC) | Phase 3 |
| Plinabulin | Chemotherapy-Induced Neutropenia (CIN) Prevention | Phase 3 |
| Plinabulin combinations | Various cancers (with radiation, PD-1/PD-L1 inhibitors) | Early stage / Investigator Trials |